• 1
    Miyake, N., J. Chilton, M. Psatha, L. Cheng, C. Andrews, W. M. Chan, et al. 2008. Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. Science 321:839843.
  • 2
    Al-Baradie, R., K. Yamada, C. St Hilaire, W. M. Chan, C. Andrews, N. McIntosh, et al. 2002. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am. J. Hum. Genet. 71:11951199.
  • 3
    Kohlhase, J., M. Heinrich, L. Schubert, M. Liebers, A. Kispert, F. Laccone, et al. 2002. Okihiro syndrome is caused by SALL4 mutations. Hum. Mol. Genet. 11:29792987.
  • 4
    Vincent, C., V. Kalatzis, S. Compain, J. Levillers, R. Slim, F. Graia, et al. 1994. A proposed new contiguous gene syndrome on 8q consists of branchio-oto-renal (BOR) syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia; implications for the mapping of the BOR gene. Hum. Mol. Genet. 3:18591866.
  • 5
    Calabrese, G., L. Stuppia, E. Morizio, F. Guanciali, F. Pompetti, R. Mingarelli, et al. 1998. Detection of an insertion deletion of region 8q13-q21.2 in a patient with Duane syndrome: implications for mapping and cloning a Duane gene. Enuropean. J. Hum. Genet. 6:187193.
  • 6
    Calabrese, G., L. Telvi, F. Capodiferro, E. Morizio, A. Pizzuti, L. Stuppia, et al. 2000. Narrowing the Duane syndrome critical region at chromosome 8q13 down to 40 kb. Eur. J. Hum. Genet. 8:319324.
  • 7
    Pizzuti, A., G. Calabrese, M. Bozzali, L. Telvi, E. Morizio, V. Guida, et al. 2002. A peptidase gene in chromosome 8q is disrupted by a balanced translocation in a duane syndrome patient. Invest. Ophthalmol. Vis. Sci. 43:36093612.
  • 8
    Rickard, S., M. Parker, W. van't Hoff, A. Barnicoat, I. Russell-Eggitt, and R. M. Winter, et al. 2001. Oto-facio-cervical (OFC) syndrome is a contiguous gene deletion syndrome involving EYA1: molecular analysis confirms allelism with BOR syndrome and further narrows the Duane syndrome critical region to 1 cM. Hum. Genet. 108:398403.
  • 9
    Monfort, S., M. Rosello, C. Orellana, S. Oltra, D. Blesa, K. Kok, et al. 2008. Detection of known and novel genomic rearrangements by array based comparative genomic hybridisation: deletion of ZNF533 and duplication of CHARGE syndrome genes. J. Med. Genet. 45:432437.
  • 10
    Lehman, A. M., J. M. Friedman, D. Chai, F. R. Zahir, M. A. Marra, L. Prisman, et al. 2009. A characteristic syndrome associated with microduplication of 8q12, inclusive of CHD7. Eur. J. Med. Genet. 52:436439.
  • 11
    Amouroux, C., M. Vincent, P. Blanchet, J. Puechberty, A. Schneider, A. M. Chaze, et al. 2012. Duplication 8q12: confirmation of a novel recognizable phenotype with duane retraction syndrome and developmental delay. Eur. J. Hum. Genet. 20:580583.
  • 12
    Luo, H., L. Xie, S. Z. Wang, J. L. Chen, C. Huang, J. Wang, et al. 2012. Duplication of 8q12 encompassing CHD7 is associated with a distinct phenotype but without duane anomaly. Eur. J. Med. Genet. 55:646649.
  • 13
    Ney, P. A., N. C. Andrews, S. M. Jane, B. Safer, M. E. Purucker, S. Weremowicz, et al. 1993. Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol. Cell. Biol. 13:56045612.
  • 14
    Haider, S., L. Cordeddu, E. Robinson, M. Movassagh, L. Siggens, A. Vujic, et al. 2012. The landscape of DNA repeat elements in human heart failure. Genome Biol. 13:R90.
  • 15
    Widschwendter, M., G. Jiang, C. Woods, H. M. Muller, H. Fiegl, G. Goebel, et al. 2004. DNA hypomethylation and ovarian cancer biology. Cancer Res. 64:44724480.
  • 16
    Schaaf, C. P., J. Wiszniewska, and A. L. Beaudet. 2011. Copy number and SNP arrays in clinical diagnostics. Annu. Rev. Genomics Hum. Genet. 12:2551.
  • 17
    Liehr, T. 2010. Cytogenetic contribution to uniparental disomy (UPD). Mol. Cytogenet. 3:8.